Ocular Microbiology, Immunology and Inflammatory Eye Diseases

Infection and immunity intersect on delicate ocular surfaces and immune-privileged tissues. This session unifies pathogenesis, diagnostics, and therapy across microbial keratitis, conjunctivitis, endophthalmitis, uveitis, and orbital inflammation—linking host–pathogen dynamics and dysbiosis to clinical trajectories and vision outcomes. We explain how epithelial barriers, tear peptides, and commensals defend the eye; how biofilms, virulence factors, and latency overcome those defenses; and how innate/adaptive responses both protect and, when misdirected, damage. Ocular Microbiology, Immunology & Inflammatory Eye Diseases translates these mechanisms into fast, accurate decisions: when to culture, when to order PCR, how to interpret imaging, and how to sequence antimicrobials, steroids, and steroid-sparing agents without fueling resistance or reactivation. If you’re exploring Vision Conference for a rigorous forum on infectious and immune eye disease, this page aligns lab findings with practical care—addressing triage, empiric coverage, de-escalation, and follow-up intervals that prevent tissue loss. We cover HSV/VZV epithelial versus stromal disease; adenoviral outbreaks and infection-control; bacterial and fungal keratitis with smear/culture/PCR strategies and fortified therapy; acanthamoeba recognition and anti-amoebic regimens; and device-related infections including post-operative endophthalmitis, with tap-inject protocols and OR prevention. For uveitis, we separate infectious from autoimmune quickly, then outline imaging (OCT, FA, ICGA) and labs that narrow etiology; we detail corticosteroid stewardship, immunomodulators (antimetabolites, calcineurin inhibitors), and biologics targeting TNF-α, IL-6, and beyond. We also review pediatric and pregnancy considerations, vaccination-linked issues, and systemic partnerships with rheumatology and ID. Finally, we connect uveitis management to quality-of-life metrics, relapse prevention, and vision preservation—underscoring antimicrobial stewardship, flare prevention, and equitable access to care during outbreaks and disasters.